Preparation of near-infrared AIEgen-active fluorescent probes for mapping amyloid-β plaques in brain tissues and living mice

C Yan, J Dai, Y Yao, W Fu, H Tian, WH Zhu, Z Guo - Nature protocols, 2023 - nature.com
Fibrillar aggregates of the amyloid-β protein (Aβ) are the main component of the senile
plaques found in brains of patients with Alzheimer's disease (AD). Development of probes …

Fluorescent diagnostic probes in neurodegenerative diseases

J Zhou, P Jangili, S Son, MS Ji, M Won… - Advanced …, 2020 - Wiley Online Library
Neurodegenerative diseases are debilitating disorders that feature progressive and
selective loss of function or structure of anatomically or physiologically associated neuronal …

Rational design of near-infrared aggregation-induced-emission-active probes: in situ mapping of amyloid-β plaques with ultrasensitivity and high-fidelity

W Fu, C Yan, Z Guo, J Zhang, H Zhang… - Journal of the …, 2019 - ACS Publications
High-fidelity mapping of amyloid-β (Aβ) plaques is critical for the early detection of
Alzheimer's disease. However, in vivo probing of Aβ plaques by commercially available …

Interrogating amyloid aggregates using fluorescent probes

A Aliyan, NP Cook, AA Martí - Chemical reviews, 2019 - ACS Publications
Amyloids are a broad class of proteins and peptides that can misfold and assemble into long
unbranched fibrils with a cross-β conformation. These misfolding and aggregation events …

Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques

C Condello, P Yuan, A Schain, J Grutzendler - Nature communications, 2015 - nature.com
In Alzheimer's disease (AD), β-amyloid (Aβ) plaques are tightly enveloped by microglia
processes, but the significance of this phenomenon is unknown. Here we show that …

Near‐Infrared Aggregation‐Induced Emission Luminogens for In Vivo Theranostics of Alzheimer's Disease

T Zhang, X Chen, C Yuan, X Pang… - Angewandte Chemie …, 2023 - Wiley Online Library
Optimized theranostic strategies for Alzheimer's disease (AD) remain almost absent from
bench to clinic. Current probes and drugs attempting to prevent β‐amyloid (Aβ) fibrosis …

Curcumin's nanomedicine formulations for therapeutic application in neurological diseases

B Salehi, D Calina, AO Docea, N Koirala… - Journal of Clinical …, 2020 - mdpi.com
The brain is the body's control center, so when a disease affects it, the outcomes are
devastating. Alzheimer's and Parkinson's disease, and multiple sclerosis are brain diseases …

Near-infrared fluorescence lifetime imaging of amyloid-β aggregates and tau fibrils through the intact skull of mice

SS Hou, J Yang, JH Lee, Y Kwon… - Nature biomedical …, 2023 - nature.com
Non-invasive methods for the in vivo detection of hallmarks of Alzheimer's disease can
facilitate the study of the progression of the disease in mouse models and may enable its …

Near-infrared fluorescent probes as imaging and theranostic modalities for amyloid-beta and tau aggregates in Alzheimer's disease

H Rai, S Gupta, S Kumar, J Yang… - Journal of Medicinal …, 2022 - ACS Publications
A person suspected of having Alzheimer's disease (AD) is clinically diagnosed for the
presence of principal biomarkers, especially misfolded amyloid-beta (Aβ) and tau proteins in …

Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease

P Thapa, SP Upadhyay, WZ Suo, V Singh, P Gurung… - Bioorganic …, 2021 - Elsevier
Abstract Chalcone [(E)-1, 3-diphenyl-2-propene-1-one], a small molecule with α, β
unsaturated carbonyl group is a precursor or component of many natural flavonoids and …